It is worth noting that GLP-1 receptor agonists show interesting and promising complementary effects to standard treatment methods used in patients with prostate cancer, The GLP-1 receptor agonist may intensify and strengthen the effect of irradiation, hormonotherapy, or chemotherapy. The gene discussed is GLP1R; the disease is prostate carcinoma.